The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Continuous Glucose Monitoring (CGM)-Global Market Insights and Sales Trends 2024
Synopsis
A continuous glucose monitoring (CGM) system may help in these cases. The system consists of a small disposable sensor inserted into the skin, a transmitter connected to the sensor by a sensor mount wirelessly transmits results to a receiver and displays results.
The global Continuous Glucose Monitoring (CGM) market size is expected to reach US$ 5979.4 million by 2029, growing at a CAGR of 3.7% from 2023 to 2029. The market is mainly driven by the significant applications of Continuous Glucose Monitoring (CGM) in various end use industries. The expanding demands from the Hospitals, Homecare Settings and Others,, are propelling Continuous Glucose Monitoring (CGM) market. Transmitters, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Sensors segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Continuous Glucose Monitoring (CGM), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Continuous Glucose Monitoring (CGM) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Continuous Glucose Monitoring (CGM) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Continuous Glucose Monitoring (CGM) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Continuous Glucose Monitoring (CGM) covered in this report include Pfizer, Baxter, Abbott Laboratories, Medtronic, Animas, Novo Nordisk, Ypsomed and GlySens, etc.
The global Continuous Glucose Monitoring (CGM) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Baxter
Abbott Laboratories
Medtronic
Animas
Novo Nordisk
Ypsomed
GlySens
Global Continuous Glucose Monitoring (CGM) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Continuous Glucose Monitoring (CGM) market, Segment by Type:
Transmitters
Sensors
Insulin Pumps
Global Continuous Glucose Monitoring (CGM) market, by Application
Hospitals
Homecare Settings
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Continuous Glucose Monitoring (CGM) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Continuous Glucose Monitoring (CGM) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
A continuous glucose monitoring (CGM) system may help in these cases. The system consists of a small disposable sensor inserted into the skin, a transmitter connected to the sensor by a sensor mount wirelessly transmits results to a receiver and displays results.
The global Continuous Glucose Monitoring (CGM) market size is expected to reach US$ 5979.4 million by 2029, growing at a CAGR of 3.7% from 2023 to 2029. The market is mainly driven by the significant applications of Continuous Glucose Monitoring (CGM) in various end use industries. The expanding demands from the Hospitals, Homecare Settings and Others,, are propelling Continuous Glucose Monitoring (CGM) market. Transmitters, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Sensors segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Continuous Glucose Monitoring (CGM), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Continuous Glucose Monitoring (CGM) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Continuous Glucose Monitoring (CGM) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Continuous Glucose Monitoring (CGM) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Continuous Glucose Monitoring (CGM) covered in this report include Pfizer, Baxter, Abbott Laboratories, Medtronic, Animas, Novo Nordisk, Ypsomed and GlySens, etc.
The global Continuous Glucose Monitoring (CGM) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Baxter
Abbott Laboratories
Medtronic
Animas
Novo Nordisk
Ypsomed
GlySens
Global Continuous Glucose Monitoring (CGM) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Continuous Glucose Monitoring (CGM) market, Segment by Type:
Transmitters
Sensors
Insulin Pumps
Global Continuous Glucose Monitoring (CGM) market, by Application
Hospitals
Homecare Settings
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Continuous Glucose Monitoring (CGM) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Continuous Glucose Monitoring (CGM) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Continuous Glucose Monitoring (CGM) Market Overview
1.1 Continuous Glucose Monitoring (CGM) Product Overview
1.2 Continuous Glucose Monitoring (CGM) Market Segment by Type
1.2.1 Transmitters
1.2.2 Sensors
1.2.3 Insulin Pumps
1.3 Global Continuous Glucose Monitoring (CGM) Market Size by Type
1.3.1 Global Continuous Glucose Monitoring (CGM) Market Size Overview by Type (2018-2029)
1.3.2 Global Continuous Glucose Monitoring (CGM) Historic Market Size Review by Type (2018-2023)
1.3.3 Global Continuous Glucose Monitoring (CGM) Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Continuous Glucose Monitoring (CGM) Sales Breakdown by Type (2018-2023)
1.4.2 Europe Continuous Glucose Monitoring (CGM) Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Continuous Glucose Monitoring (CGM) Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Continuous Glucose Monitoring (CGM) Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Continuous Glucose Monitoring (CGM) Sales Breakdown by Type (2018-2023)
2 Global Continuous Glucose Monitoring (CGM) Market Competition by Company
2.1 Global Top Players by Continuous Glucose Monitoring (CGM) Sales (2018-2023)
2.2 Global Top Players by Continuous Glucose Monitoring (CGM) Revenue (2018-2023)
2.3 Global Top Players by Continuous Glucose Monitoring (CGM) Price (2018-2023)
2.4 Global Top Manufacturers Continuous Glucose Monitoring (CGM) Manufacturing Base Distribution, Sales Area, Product Type
2.5 Continuous Glucose Monitoring (CGM) Market Competitive Situation and Trends
2.5.1 Continuous Glucose Monitoring (CGM) Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Continuous Glucose Monitoring (CGM) Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Continuous Glucose Monitoring (CGM) as of 2022)
2.7 Date of Key Manufacturers Enter into Continuous Glucose Monitoring (CGM) Market
2.8 Key Manufacturers Continuous Glucose Monitoring (CGM) Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Continuous Glucose Monitoring (CGM) Status and Outlook by Region
3.1 Global Continuous Glucose Monitoring (CGM) Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Continuous Glucose Monitoring (CGM) Historic Market Size by Region
3.2.1 Global Continuous Glucose Monitoring (CGM) Sales in Volume by Region (2018-2023)
3.2.2 Global Continuous Glucose Monitoring (CGM) Sales in Value by Region (2018-2023)
3.2.3 Global Continuous Glucose Monitoring (CGM) Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Continuous Glucose Monitoring (CGM) Forecasted Market Size by Region
3.3.1 Global Continuous Glucose Monitoring (CGM) Sales in Volume by Region (2024-2029)
3.3.2 Global Continuous Glucose Monitoring (CGM) Sales in Value by Region (2024-2029)
3.3.3 Global Continuous Glucose Monitoring (CGM) Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Continuous Glucose Monitoring (CGM) by Application
4.1 Continuous Glucose Monitoring (CGM) Market Segment by Application
4.1.1 Hospitals
4.1.2 Homecare Settings
4.1.3 Others
4.2 Global Continuous Glucose Monitoring (CGM) Market Size by Application
4.2.1 Global Continuous Glucose Monitoring (CGM) Market Size Overview by Application (2018-2029)
4.2.2 Global Continuous Glucose Monitoring (CGM) Historic Market Size Review by Application (2018-2023)
4.2.3 Global Continuous Glucose Monitoring (CGM) Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Continuous Glucose Monitoring (CGM) Sales Breakdown by Application (2018-2023)
4.3.2 Europe Continuous Glucose Monitoring (CGM) Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Continuous Glucose Monitoring (CGM) Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Continuous Glucose Monitoring (CGM) Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Continuous Glucose Monitoring (CGM) Sales Breakdown by Application (2018-2023)
5 North America Continuous Glucose Monitoring (CGM) by Country
5.1 North America Continuous Glucose Monitoring (CGM) Historic Market Size by Country
5.1.1 North America Continuous Glucose Monitoring (CGM) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Continuous Glucose Monitoring (CGM) Sales in Volume by Country (2018-2023)
5.1.3 North America Continuous Glucose Monitoring (CGM) Sales in Value by Country (2018-2023)
5.2 North America Continuous Glucose Monitoring (CGM) Forecasted Market Size by Country
5.2.1 North America Continuous Glucose Monitoring (CGM) Sales in Volume by Country (2024-2029)
5.2.2 North America Continuous Glucose Monitoring (CGM) Sales in Value by Country (2024-2029)
6 Europe Continuous Glucose Monitoring (CGM) by Country
6.1 Europe Continuous Glucose Monitoring (CGM) Historic Market Size by Country
6.1.1 Europe Continuous Glucose Monitoring (CGM) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Continuous Glucose Monitoring (CGM) Sales in Volume by Country (2018-2023)
6.1.3 Europe Continuous Glucose Monitoring (CGM) Sales in Value by Country (2018-2023)
6.2 Europe Continuous Glucose Monitoring (CGM) Forecasted Market Size by Country
6.2.1 Europe Continuous Glucose Monitoring (CGM) Sales in Volume by Country (2024-2029)
6.2.2 Europe Continuous Glucose Monitoring (CGM) Sales in Value by Country (2024-2029)
7 Asia-Pacific Continuous Glucose Monitoring (CGM) by Region
7.1 Asia-Pacific Continuous Glucose Monitoring (CGM) Historic Market Size by Region
7.1.1 Asia-Pacific Continuous Glucose Monitoring (CGM) Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Continuous Glucose Monitoring (CGM) Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Continuous Glucose Monitoring (CGM) Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Continuous Glucose Monitoring (CGM) Forecasted Market Size by Region
7.2.1 Asia-Pacific Continuous Glucose Monitoring (CGM) Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Continuous Glucose Monitoring (CGM) Sales in Value by Region (2024-2029)
8 Latin America Continuous Glucose Monitoring (CGM) by Country
8.1 Latin America Continuous Glucose Monitoring (CGM) Historic Market Size by Country
8.1.1 Latin America Continuous Glucose Monitoring (CGM) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Continuous Glucose Monitoring (CGM) Sales in Volume by Country (2018-2023)
8.1.3 Latin America Continuous Glucose Monitoring (CGM) Sales in Value by Country (2018-2023)
8.2 Latin America Continuous Glucose Monitoring (CGM) Forecasted Market Size by Country
8.2.1 Latin America Continuous Glucose Monitoring (CGM) Sales in Volume by Country (2024-2029)
8.2.2 Latin America Continuous Glucose Monitoring (CGM) Sales in Value by Country (2024-2029)
9 Middle East and Africa Continuous Glucose Monitoring (CGM) by Country
9.1 Middle East and Africa Continuous Glucose Monitoring (CGM) Historic Market Size by Country
9.1.1 Middle East and Africa Continuous Glucose Monitoring (CGM) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Continuous Glucose Monitoring (CGM) Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Continuous Glucose Monitoring (CGM) Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Continuous Glucose Monitoring (CGM) Forecasted Market Size by Country
9.2.1 Middle East and Africa Continuous Glucose Monitoring (CGM) Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Continuous Glucose Monitoring (CGM) Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pfizer Continuous Glucose Monitoring (CGM) Products Offered
10.1.5 Pfizer Recent Development
10.2 Baxter
10.2.1 Baxter Company Information
10.2.2 Baxter Introduction and Business Overview
10.2.3 Baxter Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Baxter Continuous Glucose Monitoring (CGM) Products Offered
10.2.5 Baxter Recent Development
10.3 Abbott Laboratories
10.3.1 Abbott Laboratories Company Information
10.3.2 Abbott Laboratories Introduction and Business Overview
10.3.3 Abbott Laboratories Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Abbott Laboratories Continuous Glucose Monitoring (CGM) Products Offered
10.3.5 Abbott Laboratories Recent Development
10.4 Medtronic
10.4.1 Medtronic Company Information
10.4.2 Medtronic Introduction and Business Overview
10.4.3 Medtronic Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Medtronic Continuous Glucose Monitoring (CGM) Products Offered
10.4.5 Medtronic Recent Development
10.5 Animas
10.5.1 Animas Company Information
10.5.2 Animas Introduction and Business Overview
10.5.3 Animas Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Animas Continuous Glucose Monitoring (CGM) Products Offered
10.5.5 Animas Recent Development
10.6 Novo Nordisk
10.6.1 Novo Nordisk Company Information
10.6.2 Novo Nordisk Introduction and Business Overview
10.6.3 Novo Nordisk Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Novo Nordisk Continuous Glucose Monitoring (CGM) Products Offered
10.6.5 Novo Nordisk Recent Development
10.7 Ypsomed
10.7.1 Ypsomed Company Information
10.7.2 Ypsomed Introduction and Business Overview
10.7.3 Ypsomed Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Ypsomed Continuous Glucose Monitoring (CGM) Products Offered
10.7.5 Ypsomed Recent Development
10.8 GlySens
10.8.1 GlySens Company Information
10.8.2 GlySens Introduction and Business Overview
10.8.3 GlySens Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2018-2023)
10.8.4 GlySens Continuous Glucose Monitoring (CGM) Products Offered
10.8.5 GlySens Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Continuous Glucose Monitoring (CGM) Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Continuous Glucose Monitoring (CGM) Industrial Chain Analysis
11.4 Continuous Glucose Monitoring (CGM) Market Dynamics
11.4.1 Continuous Glucose Monitoring (CGM) Industry Trends
11.4.2 Continuous Glucose Monitoring (CGM) Market Drivers
11.4.3 Continuous Glucose Monitoring (CGM) Market Challenges
11.4.4 Continuous Glucose Monitoring (CGM) Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Continuous Glucose Monitoring (CGM) Distributors
12.3 Continuous Glucose Monitoring (CGM) Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
